MedTrace Logo

A Trial Investigating Lu AF28996 in Healthy Adult Participants

NCT06277609 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2024-06-11

No results posted yet for this study

Summary

The purpose of this study is to investigate repeated doses of Lu AF28996 in healthy participants and co-administered with two other compounds, and in a separate cohort following co-administration with antibiotics, to see how well the doses are tolerated and what the body does to the drug after administering it.

Conditions

  • Healthy Participants

Interventions

DRUG

Lu AF28996

Capsule

DRUG

Acetylsalicylic Acid

Tablet

DRUG

Mefenamic Acid

Tablet

DRUG

Amoxicillin/clavulanic acid

Tablet

Sponsors & Collaborators

  • H. Lundbeck A/S

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-27
Primary Completion
2024-05-19
Completion
2024-05-19
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06277609 on ClinicalTrials.gov